GANX logo

Gain Therapeutics, Inc. (GANX)

Profile

Full Name

Gain Therapeutics, Inc.

Ticker

NASDAQ: GANX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 19, 2021

Indexes

Not included

Website

https://gaintherapeutics.com

Employees

23

Key Details

Price

$2.22(15.62%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(-100.00% YoY)

Annual EPS

-$0.89(47.88% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.22
    GANX price is $2.22

    30-Day Relative Volume

    4.31
    GANX 30-day relative volume is 4.31

    Price Performance

    Price Most Recent Change

    +15.62%
    GANX price was up +15.62% on Oct 6, 2025

    Price YTD Change

    +2.78%
    GANX price is up +2.78% since January 1st

    Price 1-Year Change

    +21.98%
    GANX price is up +21.98% year-on-year

    Price 3-Year Change

    -28.85%
    GANX price is down -28.85% over the past 3 years

    Price Range

    Price All-Time High

    $17.93
    GANX price is currently -87.62% below its historical high of $17.93

    Price 3-Year Low

    $0.89
    GANX price is currently +149.44% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $79.81M
    GANX market cap is $79.81 million

    Market Cap 3-Year Change

    +115.25%
    GANX market cap is up +115.25% over the past 3 years

    Market Cap All-Time High

    $187.65M
    GANX market cap is currently -57.47% below its historical high of $187.65 million

    Market Cap Sector Percentile

    36.87%
    GANX market cap is higher than 36.87% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +38.47%
    GANX shares outstanding is up +38.47% year-on-year

    Shares Outstanding 3-Year Change

    +202.51%
    GANX shares outstanding is up +202.51% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.05
    GANX beta is 1.05

    200-day SMA

    $1.90
    GANX price is currently +16.63% above its 200-day simple moving average

    50-day SMA

    $1.71
    GANX price is currently +29.53% above its 50-day simple moving average

    14-Day RSI

    73.41
    GANX 14-day relative strength index is 73.41

    Volume

    4.31
    GANX 30-day relative volume is 4.31

    ATR

    $0.16
    GANX average true range is $0.16

    10-day Historical Volatility

    78.61%
    GANX 10-day historical volatility is 78.61%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    GANX annual revenue is $0.00

    Revenue Analysts Estimate

    -
    GANX annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    -100%
    GANX annual revenue is down -100% year-on-year

    Revenue Sector Percentile

    28.74%
    GANX annual revenue is higher than 28.74% of companies in Healthcare sector

    EPS

    EPS

    -$0.89
    GANX annual earnings per share is -$0.89

    EPS Analysts Estimate

    -$0.67
    GANX annual earnings per share is currently +33.79% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +47.88%
    GANX annual earnings per share is up +47.88% year-on-year

    EPS Sector Percentile

    58.23%
    GANX annual earnings per share is higher than 58.23% of companies in Healthcare sector

    Profit

    Gross Profit

    -$84.10K
    GANX annual gross profit is -$84.10 thousand

    Gross Margin

    -
    GANX annual gross profit margin value is unknown

    Operating Profit

    -$20.35M
    GANX annual operating income is -$20.35 million

    Operating Margin

    -
    GANX annual operating profit margin value is unknown

    Net Income

    -$20.41M
    GANX annual net profit is -$20.41 million

    Net Margin

    -
    GANX annual net profit margin value is unknown

    Expenses

    Total Expenses

    $20.35M
    GANX annual total expenses is $20.35 million

    Operating Expenses

    $20.35M
    GANX annual total operating expenses is $20.35 million

    Cost Of Goods Sold

    $84.10K
    GANX annual cost of goods sold is $84.10 thousand

    Selling, General & Administrative Expenses

    $9.56M
    GANX annual SG&A is $9.56 million

    Depreciation & Amortization

    $84.10K
    GANX annual D&A is $84.10 thousand

    Interest Expense

    $0.00
    GANX annual interest expense is $0.00

    Income Tax

    $536.80K
    GANX annual income tax is $536.80 thousand

    EBIT & EBITDA

    EBIT

    -$20.35M
    GANX annual earnings before interest & taxes is -$20.35 million

    EBITDA

    -$20.27M
    GANX annual EBITDA is -$20.27 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $12.12M
    GANX annual total assets is $12.12 million

    Non Current Assets

    $521.40K
    GANX annual long term assets is $521.40 thousand

    Current Assets

    $11.60M
    GANX annual total current assets is $11.60 million

    Cash and Cash Equivalents

    $10.39M
    GANX annual cash & cash equivalents is $10.39 million

    Accounts Receivable

    -
    GANX annual accounts receivable value is unknown

    Inventory

    $0.00
    GANX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $4.78M
    GANX annual total liabilities is $4.78 million

    Long Term Liabilities

    $873.00K
    GANX annual total long term liabilities is $873.00 thousand

    Current Liabilities

    $3.91M
    GANX annual current liabilities is $3.91 million

    Accounts Payable

    $946.30K
    GANX annual accounts payable is $946.30 thousand

    Debt

    Total Debt

    $653.00K
    GANX annual total debt is $653.00 thousand

    Total Debt 1-Year Change

    -36.44%
    GANX annual total debt is down -36.44% year-on-year

    Long Term Debt

    $381.90K
    GANX annual long term debt is $381.90 thousand

    Short Term Debt

    $271.10K
    GANX annual short term debt is $271.10 thousand

    Equity & Capital

    Shareholders Equity

    $7.34M
    GANX annual stockholders equity is $7.34 million

    Book Value

    $7.34M
    GANX annual book value is $7.34 million

    Retained Earnings

    -$81.19M
    GANX annual retained earnings is -$81.19 million

    Working Capital

    $7.69M
    GANX annual working capital is $7.69 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$18.87M
    GANX annual cash from operations is -$18.87 million

    Cash From Operations 1-Year Change

    -0.04%
    GANX annual cash from operations is down -0.04% year-on-year

    Cash From Investing

    $4.98M
    GANX annual cash from investing is $4.98 million

    Cash From Investing 1-Year Change

    -51.31%
    GANX annual cash from investing is down -51.31% year-on-year

    Cash From Financing

    $13.01M
    GANX annual cash from financing is $13.01 million

    Cash From Financing 1-Year Change

    +2.93%
    GANX annual cash from financing is up +2.93% year-on-year

    CAPEX

    CAPEX

    $22.50K
    GANX annual capital expenditures is $22.50 thousand

    CAPEX 1-Year Change

    +46.1%
    GANX annual capital expenditures is up +46.1% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$18.90M
    GANX annual free cash flow is -$18.90 million

    Free Cash Flow 1-Year Change

    -0.08%
    GANX annual free cash flow is down -0.08% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    GANX annual gross profit margin value is unknown

    Operating Margin

    -
    GANX annual operating profit margin value is unknown

    Net Margin

    -
    GANX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -132.83%
    GANX annual return on assets is -132.83%

    ROE

    -204.95%
    GANX annual return on equity is -204.95%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    GANX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    GANX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    21.59
    GANX price to book ratio is 21.59

    PB Ratio Sector Percentile

    94.77%
    GANX price to book ratio is higher than 94.77% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    GANX price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    GANX price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $73.79M
    GANX enterprise value is $73.79 million

    Enterprise Value Sector Percentile

    40.61%
    GANX enterprise value is higher than 40.61% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.30
    GANX EV/EBITDA is -4.30

    EV/EBITDA Sector Percentile

    27%
    GANX EV/EBITDA is higher than 27% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.97
    GANX annual current ratio is 2.97

    Quick Ratio

    2.97
    GANX annual quick ratio is 2.97

    Leverage

    Debt To Equity

    0.09
    GANX annual debt to equity ratio is 0.09

    Interest Coverage Ratio

    -
    GANX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    GANX piotroski f-score value is unknown

    Altman Z-Score

    -4.15
    GANX altman z-score is -4.15

    Analyst ratings

    Recent major analysts updates

    Sep 8, 25 BTIG
    Buy
    Aug 13, 25 Roth Capital
    Buy
    Jul 3, 25 HC Wainwright & Co.
    Buy
    May 19, 25 HC Wainwright & Co.
    Buy
    Mar 28, 25 Chardan Capital
    Buy
    Mar 17, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 Scotiabank
    Sector Outperform
    Dec 24, 24 Roth MKM
    Buy
    Dec 5, 24 Roth MKM
    Buy
    Nov 25, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with GANX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Gain Therapeutics, Inc.?
    • Does Gain Therapeutics, Inc. pay dividends?
    • What sector is Gain Therapeutics, Inc. in?
    • What industry is Gain Therapeutics, Inc. in?
    • What country is Gain Therapeutics, Inc. based in?
    • When did Gain Therapeutics, Inc. go public?
    • Is Gain Therapeutics, Inc. in the S&P 500?
    • Is Gain Therapeutics, Inc. in the NASDAQ 100?
    • Is Gain Therapeutics, Inc. in the Dow Jones?
    • When was Gain Therapeutics, Inc.'s last earnings report?
    • When does Gain Therapeutics, Inc. report earnings?

    What is the ticker symbol for Gain Therapeutics, Inc.?

    The ticker symbol for Gain Therapeutics, Inc. is NASDAQ:GANX

    Does Gain Therapeutics, Inc. pay dividends?

    No, Gain Therapeutics, Inc. does not pay dividends

    What sector is Gain Therapeutics, Inc. in?

    Gain Therapeutics, Inc. is in the Healthcare sector

    What industry is Gain Therapeutics, Inc. in?

    Gain Therapeutics, Inc. is in the Biotechnology industry

    What country is Gain Therapeutics, Inc. based in?

    Gain Therapeutics, Inc. is headquartered in United States

    When did Gain Therapeutics, Inc. go public?

    Gain Therapeutics, Inc.'s initial public offering (IPO) was on March 19, 2021

    Is Gain Therapeutics, Inc. in the S&P 500?

    No, Gain Therapeutics, Inc. is not included in the S&P 500 index

    Is Gain Therapeutics, Inc. in the NASDAQ 100?

    No, Gain Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Gain Therapeutics, Inc. in the Dow Jones?

    No, Gain Therapeutics, Inc. is not included in the Dow Jones index

    When was Gain Therapeutics, Inc.'s last earnings report?

    Gain Therapeutics, Inc.'s most recent earnings report was on March 25, 2025

    When does Gain Therapeutics, Inc. report earnings?

    The date for Gain Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page